A series of reports and estimates collectively spotlight a turbulent phase for
Alexandria Real Estate Equities (ARE). ARE reported 4Q25 and 2025 net losses per share of $6.35 and $8.44 respectively, and an adjusted FFO per share of $2.16 for 4Q25. The news of
share price downfall, dividend cuts and
large impairments led to heightened concerns among the shareholders and stock analysts. However, they also announced
cash tender offers and began an
$800 million tender offer at their Pasadena headquarters. Even with their shares rebounding, the balance sheet was reset and the
dividend revised. Following the impairments and dividend cut, despite a 6.6% downfall, the company's stock was raised to hold at Zacks Research. They also announced tax treatments for year 2025 distributions and updated FY 2026 earnings guidance. Despite facing lawsuits and impairment concerns, the
valuation of ARE is constantly revised, indicating a possible turning point for its Life Science REIT Model. While some suggest that ARE presents potential opportunity after a massive drop amid REIT downturn, others ponder it to be a value trap after a 45% dividend cut.
Alexandria Real Estate Equities ARE News Analytics from Fri, 31 Oct 2025 07:00:00 GMT to Sat, 31 Jan 2026 13:16:13 GMT -
Rating -7
- Innovation -5
- Information 8
- Rumor -6
